XAF1 and diabetes mellitus: The present study demonstrated that low-grade inflammation that causes macrophage activation under obesity conditions induces β-cell dysfunction and exacerbates diabetes due to enhanced β-cell apoptosis mediated by XAF1 expression, in addition to decreased insulin sensitivity through adipose tissue inflammation.